In Mexico, it can be tricky to protect data exclusivity, but prospective international agreements may provide a solution, as Jose Trigueros explains.
Data exclusivity is usually discussed in academic circles, mainly due to enforcement complexities and when cases are brought against the Federal Commission for the Protection against Sanitary Risks, the government branch in charge of issuing of marketing authorisations for drugs and agrichemicals.
However, data exclusivity protection is a crucial element for securing marketing exclusivity for both the pharmaceutical and agrichemical sectors, especially for orphan drugs and also for molecules the patent protection of which may be compromised in some manner, or simply unavailable.
For that reason, data exclusivity is a topic which appears regularly in the negotiation of bilateral and multilateral international treaties,including IP clauses, to which Mexico is a party.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Mexico, pharmaceutical, agrichemical, TPP, COFEPRIS, data exclusivity